Sign In
Buy BSTC
$88.53
+0 (+0%)
At Close: May 27, 2022
BioSpecifics Technologies Q1 EPS $0.610 Up From $0.600 YoY, Sales $9.669M Up From $8.129M YoY
12:12pm, Monday, 11'th May 2020BioSpecifics Reports First Quarter 2020 Financial and Operating Results
12:05pm, Monday, 11'th May 2020
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product markete
BioSpecifics Names Joseph Truitt as Permanent Chief Executive Officer
12:00pm, Monday, 11'th May 2020
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product markete
BioDelivery Sciences: Undervalued $5 Biopharma Still Growing Despite COVID-19
07:37am, Monday, 11'th May 2020
The impacts of the coronavirus outbreak have affected almost every industry in the market, even biotech and biopharma. However, one small biopharma called BioDe
Chiasma, Inc. (CHMA) CEO Raj Kannan on Q1 2020 Results - Earnings Call Transcript
04:04am, Monday, 11'th May 2020
Chiasma, Inc. (NASDAQ:CHMA) Q1 2020 Earnings Conference Call May 7, 2020 17:00 ET Company Participants Dawn Schottlandt - Vice President, IR & Corporate Com
Bausch (BHC) Down on Q1 Earnings & Sales Miss, View Trimmed
12:00am, Friday, 08'th May 2020
Stocks Analysis by Zacks Investment Research covering: Microsoft Corporation, Bausch Health Companies Inc, Endo International PLC, Mallinckrodt. Read Zacks Investment Research's latest article on Inve
Neurocrine Biosciences Still Making Smart Moves To Build Long-Term Value
08:40pm, Thursday, 07'th May 2020
Ingrezza sales exceeded Street expectations, and management's pre-Covid-19 efforts in telemedicine may help reduce the outbreak's impact on prescription growth
Endo International plc's (ENDP) CEO Blaise Coleman on Q1 2020 Results - Earnings Call Transcript
03:37pm, Thursday, 07'th May 2020
Endo International plc (NASDAQ:ENDP) Q1 2020 Results Earnings Conference Call May 07, 2020, 08:00 AM ET Company Participants Laure Park - Senior Vice President,
Zacks.com featured highlights include: BioSpecificsTechnologies, eXp World, Elbit Systems and KoninklijkeVopak
01:49pm, Thursday, 07'th May 2020
Zacks.com featured highlights include: BioSpecificsTechnologies, eXp World, Elbit Systems and KoninklijkeVopak
Neurocrine Bioscineces' (NBIX) CEO Kevin Gorman on Q1 2020 Results - Earnings Call Transcript
04:03am, Thursday, 07'th May 2020
Neurocrine Bioscineces, Inc. (NASDAQ:NBIX) Q1 2020 Earnings Conference Call May 6, 2020 4:30 PM ET Company Participants Kevin Gorman – Chief Executive Officer T
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
4 Stocks With Rising Cash Flows to Beat Coronavirus Crisis
12:00am, Wednesday, 06'th May 2020The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
BioSpecifics Technologies (NASDAQ:BSTC) Stock Rating Upgraded by BidaskClub
10:08am, Thursday, 30'th Apr 2020
BioSpecifics Technologies (NASDAQ:BSTC) was upgraded by equities research analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Thursday, BidAskClub reports. BSTC
